Quidel | QDEL - Assets


Quidel reported $5.72B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.97B 902M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Haemonetics USD 2.37B 30.52M Jun/2026
Illumina USD 6.65B 91M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Merit Medical Systems USD 2.86B 144.34M Jun/2026
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Neogen USD 3.35B 13M Mar/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 751.85M 30.51M Jun/2026
Quidel USD 5.72B 86.6M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
STAAR Surgical USD 475.2M 24.09M Jun/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Waters USD 24.75B 220M Jun/2026